1. Home
  2. NUW vs LFCR Comparison

NUW vs LFCR Comparison

Compare NUW & LFCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nuveen AMT-Free Municipal Value Fund

NUW

Nuveen AMT-Free Municipal Value Fund

N/A

Current Price

$13.15

Market Cap

245.0M

Sector

Finance

ML Signal

N/A

Logo Lifecore Biomedical Inc.

LFCR

Lifecore Biomedical Inc.

N/A

Current Price

$6.39

Market Cap

243.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NUW
LFCR
Founded
N/A
1986
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
245.0M
243.4M
IPO Year
2008
1996

Fundamental Metrics

Financial Performance
Metric
NUW
LFCR
Price
$13.15
$6.39
Analyst Decision
Hold
Analyst Count
0
5
Target Price
N/A
★ $6.28
AVG Volume (30 Days)
65.0K
★ 314.8K
Earning Date
01-01-0001
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $557,559,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$8.97
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 6.36
52 Week Low
$12.70
$3.63
52 Week High
$14.70
$8.98

Technical Indicators

Market Signals
Indicator
NUW
LFCR
Relative Strength Index (RSI) 38.58 59.88
Support Level $12.79 $6.32
Resistance Level $13.53 $6.48
Average True Range (ATR) 0.25 0.03
MACD -0.08 -0.04
Stochastic Oscillator 14.97 42.86

Price Performance

Historical Comparison
NUW
LFCR

About NUW Nuveen AMT-Free Municipal Value Fund

Nuveen AMT-Free Municipal Value Fund is a diversified closed-end management investment company. The Fund's primary investment objective is to provide current income exempt from regular federal income tax. The Fund's secondary investment objective is to enhance portfolio value and total return.

About LFCR Lifecore Biomedical Inc.

Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that provides services in the development, fill, and finish of complex sterile injectable pharmaceutical products in syringes, vials, and cartridges. The group recognizes revenue in two different product categories, CDMO and HA manufacturing.

Share on Social Networks: